| Deborah Lynn Roper, CRNA | |
|
272 Hospital Rd, Chillicothe, OH 45601-9031 | |
| (740) 779-7540 | |
| (740) 779-7867 |
| Full Name | Deborah Lynn Roper |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 272 Hospital Rd, Chillicothe, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376654541 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | CRNA0448 (Arizona) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | NA09268 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Lynn Roper, CRNA 272 Hospital Rd, Suite 3, Chillicothe, OH 45601-9031 Ph: (740) 779-8234 | Deborah Lynn Roper, CRNA 272 Hospital Rd, Chillicothe, OH 45601-9031 Ph: (740) 779-7540 |
News Archive
Stem cells derived from abdominal fat—used along with a synthetic bone grafting material—are a potentially valuable new approach to repairing skull defects after brain surgery, according to a study in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Research using registry data can contribute a great deal to the improvement of health and healthcare. Sweden is uniquely positioned in this respect, but the resources remain under-exploited, and there are methodological and financing problems that need resolving.
Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.
Cyberonics, Inc., a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration approved a significant expansion of options for Magnetic Resonance Imaging use by patients who have the VNS Therapy System.
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant.
› Verified 9 days ago
Mr. Andrew Alan Parsley, MSN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7500 | |
Cathy Sheehy, RN Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 513-672-3309 Fax: 513-672-3323 | |
Madison Nicole Cline, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7500 | |
Timothy King, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7540 | |
Chad M Ball, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7562 | |
Julia Froehlich, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 272 Hospital Rd, Chillicothe, OH 45601 Phone: 740-779-7540 | |
Joy A Bennett, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 159 E 2nd St, Chillicothe, OH 45601 Phone: 740-773-6347 |